Cargando…

Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence

Cellular senescence is an irreversible side effect of some pharmaceuticals which can contribute to tissue degeneration. OBJECTIVE: To determine whether pharmaceutical glucocorticoids induce senescence in tenocytes. METHODS: Features of senescence (β-galactosidase activity at pH 6 (SA-β-gal) and acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poulsen, Raewyn C, Watts, Anna C, Murphy, Richard J, Snelling, Sarah J, Carr, Andrew J, Hulley, Philippa A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Basic and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078757/ https://www.ncbi.nlm.nih.gov/pubmed/23727633 http://dx.doi.org/10.1136/annrheumdis-2012-203146

Ejemplares similares

Cell proliferation is a key determinant of the outcome of FOXO3a activation
por: Poulsen, Raewyn C., et al.
Publicado: (2015)

Regulation of Hypoxia-Induced Cell Death in Human Tenocytes
por: Liang, Min, et al.
Publicado: (2012)

Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways
por: Bernhart, Eva, et al.
Publicado: (2014)

EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma
por: Ding, Jie, et al.
Publicado: (2022)

Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells
por: Kim, Ella L., et al.
Publicado: (2010)

p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
por: Sonnemann, J, et al.
Publicado: (2014)

Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss
por: Kaur, K, et al.
Publicado: (2009)

Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis
por: Koenen, Mascha, et al.
Publicado: (2018)

A genetic mouse model with postnatal Nf1 and p53 loss recapitulates the histology and transcriptome of human malignant peripheral nerve sheath tumor
por: Inoue, Akira, et al.
Publicado: (2021)

Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice
por: Qin, Yuan, et al.
Publicado: (2020)

Sox2(+) cells in Sonic Hedgehog-subtype medulloblastoma resist p53-mediated cell-cycle arrest response and drive therapy-induced recurrence
por: Treisman, Daniel M, et al.
Publicado: (2019)

Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53
por: Arya, A K, et al.
Publicado: (2010)

p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010)

Premature senescence of T-cell subsets in axial spondyloarthritis
por: Fessler, Johannes, et al.
Publicado: (2016)

The impact of endogenous annexin A1 on glucocorticoid control of inflammatory arthritis
por: Patel, Hetal B, et al.
Publicado: (2012)

Glucocorticoid receptor expression on circulating leukocytes differs between healthy male and female adults
por: Lu, Kim D., et al.
Publicado: (2017)

The tenocyte phenotype of human primary tendon cells in vitro is reduced by glucocorticoids
por: Spang, Christoph, et al.
Publicado: (2016)

p28, A first in class peptide inhibitor of cop1 binding to p53
por: Yamada, T, et al.
Publicado: (2013)

Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut
por: Bach, S P, et al.
Publicado: (2006)

Heterogeneity and excitability of BRAF(V600E)-induced tumors is determined by Akt/mTOR-signaling state and Trp53-loss
por: Cases-Cunillera, Silvia, et al.
Publicado: (2021)

Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region
por: Peters, Marjolein J, et al.
Publicado: (2013)

Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
por: de Bruijn, M T, et al.
Publicado: (2010)

Genome-wide association analysis identifies a meningioma risk locus at 11p15.5
por: Claus, Elizabeth B, et al.
Publicado: (2018)

Glucocorticoid therapy and risk of bladder cancer
por: Dietrich, K, et al.
Publicado: (2009)

Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levels
por: Giovannetti, E, et al.
Publicado: (2007)

Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma
por: Chen, L, et al.
Publicado: (2014)

FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas
por: Sharaf, Radwa, et al.
Publicado: (2021)

MDSCs-derived GPR84 induces CD8(+) T-cell senescence via p53 activation to suppress the antitumor response
por: Liu, Jinyan, et al.
Publicado: (2023)

Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine
por: Dudley, A C, et al.
Publicado: (2008)

Directing the Differentiation of Parthenogenetic Stem Cells into Tenocytes for Tissue‐Engineered Tendon Regeneration
por: Liu, Wei, et al.
Publicado: (2016)

Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas
por: Ball, Matthew K, et al.
Publicado: (2020)

The brain-penetrant cell-cycle inhibitor p28 sensitizes brain metastases to DNA-damaging agents
por: Mander, Sunam, et al.
Publicado: (2023)

TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors
por: Cantero, Diana, et al.
Publicado: (2020)

Substance P Is a Mechanoresponsive, Autocrine Regulator of Human Tenocyte Proliferation
por: Backman, Ludvig J., et al.
Publicado: (2011)

TP53 Mutation in Correlation to Immunohistochemical Expression of P53 Protein in Patients with Hepatocellular Carcinoma
por: Nikolova, Dafina, et al.
Publicado: (2018)

Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing
por: Li, Chao, et al.
Publicado: (2022)

Inhibitory effect of PDGF-BB and serum-stimulated responses in vascular smooth muscle cell proliferation by hinokitiol via up-regulation of p21 and p53
por: Li, Jiun-Yi, et al.
Publicado: (2018)

Transcriptional regulation of CDKN2A/p16 by sirtuin 7 in senescence
por: Rodríguez, Sergio, et al.
Publicado: (2022)

The Central Sirtuin 1/p53 Pathway Is Essential for the Orexigenic Action of Ghrelin
por: Velásquez, Douglas A., et al.
Publicado: (2011)

Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein
por: Fischer, Holger, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6onib682p6p8ki1o0k99pag1f3